Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$29.0 - $40.64 $799,095 - $1.12 Million
-27,555 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$33.21 - $43.99 $140,876 - $186,605
-4,242 Reduced 13.34%
27,555 $1.13 Million
Q4 2020

Feb 11, 2021

BUY
$19.26 - $45.61 $612,410 - $1.45 Million
31,797 New
31,797 $1.4 Million
Q2 2020

Aug 13, 2020

SELL
$18.45 - $25.51 $730,786 - $1.01 Million
-39,609 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$15.11 - $28.71 $14,566 - $27,676
-964 Reduced 2.38%
39,609 $806,000
Q4 2019

Feb 11, 2020

BUY
$17.5 - $28.66 $710,027 - $1.16 Million
40,573 New
40,573 $1.05 Million
Q1 2018

May 14, 2018

SELL
$19.86 - $35.92 $483,511 - $874,508
-24,346 Closed
0 $0
Q4 2017

Feb 12, 2018

SELL
$19.71 - $36.79 $357,499 - $667,297
-18,138 Reduced 42.69%
24,346 $867,000
Q3 2017

Nov 08, 2017

BUY
$7.31 - $20.8 $310,558 - $883,667
42,484
42,484 $835,000

Others Institutions Holding XOMA

About XOMA Corp


  • Ticker XOMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,450,800
  • Market Cap $338M
  • Description
  • XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...
More about XOMA
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.